|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 GBX | +4.88% |
|
-2.27% | +9.14% |
| Apr. 05 | RUA Life Sciences expects flat annual revenue on strong second half | AN |
| Apr. 05 | RUA Life Sciences plc Provides Revenue Guidance for the Year Ended 31 March 2024 | CI |
RUA Life Sciences plc reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was GBP 0.794 million compared to GBP 1.1 million a year ago. Net loss was GBP 1.01 million compared to GBP 1.14 million a year ago.
Basic loss per share from continuing operations was GBP 0.0455 compared to GBP 0.0515 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.14% | 8.31M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
RUA LIFE SCIENCES PLC 
